Predictive Safety Testing Consortium have proposed glutamate dehydrogenase (GLDH) as a more liver-specific biomarker for ...

Damaged human livers can repair themselves. Even livers badly scarred from excessive alcohol use, including alcohol-related ...

In 2021, liver disease led to 2.7 million emergency department (ED) visits in the U.S., 2 million hospitalizations, and ...

A deeper understanding of a gene that predisposes patients to fatty liver disease may open new avenues for treatment of the ...

The tool reduces pathologist variability in liver biopsy assessment during trials of treatments for metabolic ...

Parasitic diseases are still the primary diseases that seriously threaten human health and life, and liver pathology is the leading cause of morbidity and ...

EMA’s human medicines committee qualifies first AI tool to diagnose inflammatory liver disease in biopsy samples: Amsterdam, The Netherlands Saturday, March 22, 2025, 16:00 Hrs ...

AI-powered digital pathology specialist PathAI, based in Boston in the US, said that AIM-NASH AI Assist is designed to assist ...

PathAI, a global leader in AI-powered pathology, today announced that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has granted full qualification for ...

MASH has long been a challenging and progressive liver disease, characterized by fat build-up and inflammation that, if left ...

HistoIndex, a global leader in stain-free digital pathology solutions for managing fibrotic diseases, has announced the ...

Metabolic dysfunction-associated steatohepatitis (MASH) is a liver disease that progresses without symptoms and is associated with significant global public health concerns.